BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33965959)

  • 21. Incidental prostatic cancer: repeat TURP or biopsy?
    Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP
    Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic Comorbidity Burden Using the ACTIONS Phenotype Predicts Urologic Medication Discontinuation Following Transurethral Resection of the Prostate.
    Zhang JH; Gill BA; Wilkins L; Ramkumar RR; Shoskes DA
    Urology; 2019 May; 127():91-96. PubMed ID: 30822484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.
    Mayer EK; Kroeze SG; Chopra S; Bottle A; Patel A
    BJU Int; 2012 Dec; 110(11):1595-601. PubMed ID: 22540956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
    Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
    Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
    Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
    Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining and discriminating responders from non-responders following transurethral resection of the prostate.
    Sagen E; Hedelin H; Nelzén O; Peeker R
    Scand J Urol; 2018; 52(5-6):437-444. PubMed ID: 30681023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Zeng G; Zhong W
    Prostate; 2010 Dec; 70(16):1788-98. PubMed ID: 20583137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system.
    De Nunzio C; Lombardo R; Autorino R; Cicione A; Cindolo L; Damiano R; De Sio M; Falsaperla M; Franco G; Gacci M; Leonardo C; Presicce F; Tubaro A
    Int Urol Nephrol; 2013 Aug; 45(4):951-9. PubMed ID: 23722819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Accuracy of Transperineal MRI Fusion Biopsy in Comparison to Transrectal Biopsy with Regard to Incidental Histopathological Findings in Transurethral Resection of the Prostate.
    Dieffenbacher SC; Popeneciu IV; Radtke JP; Teber D; Hohenfellner M; Hadaschik BA; Hatiboglu G
    Urol Int; 2017; 99(2):162-167. PubMed ID: 28190012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Incidence of Incidental Prostate Cancer in Transurethral Resection of Prostate Specimens in China. The Value of Pathologic Review.
    Lin J; Yu X; Yang X; Jin J; Zhou L; Liu L; Su J; Li Y; Shang M
    Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):31-7. PubMed ID: 27363064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Testosterone Level on Lower Urinary Tract Symptoms.
    Crawford ED; Poage W; Nyhuis A; Price DA; Dowsett SA; Muram D
    Am J Mens Health; 2016 Sep; 10(5):440-2. PubMed ID: 26077271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transurethral resection of prostate with plasmakinetic energy: 100 months results of a prospective randomized trial.
    Muslumanoglu AY; Yuruk E; Binbay M; Akman T
    BJU Int; 2012 Aug; 110(4):546-9. PubMed ID: 22115409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Management of Incidental Prostate Cancer Following TURP.
    Matanhelia DM; Croghan S; Nason GJ; O’Connell C; Galvin DJ
    Ir Med J; 2019 Feb; 112(2):866. PubMed ID: 30875166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    J Urol; 2015 Feb; 193(2):570-8. PubMed ID: 25219699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men.
    Teoh JY; Chan CK; Wang MH; Leung CH; Chan ES; Chiu PK; Yee CH; Wong HM; Hou SS; Ng CF
    Asian J Androl; 2019; 21(5):468-472. PubMed ID: 30648670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.
    Kim SJ; Al Hussein Alawamlh O; Chughtai B; Lee RK
    Curr Urol Rep; 2018 Aug; 19(10):85. PubMed ID: 30128964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP.
    Falahatkar S; Mokhtari G; Moghaddam KG; Asadollahzade A; Farzan A; Shahab E; Ghasemi A; Allahkhah A; Esmaeili S
    Int Braz J Urol; 2014; 40(3):346-55. PubMed ID: 25010300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.
    Chandra Engel J; Palsdottir T; Aly M; Egevad L; Grönberg H; Eklund M; Nordström T
    Scand J Urol; 2020 Feb; 54(1):1-6. PubMed ID: 31876229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.